Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Johnson & Johnson Q1 2024 Adj EPS $2.71 Beats $2.64 Estimate, Sales $21.383B Miss $21.398B Estimate

Author: Benzinga Newsdesk | April 16, 2024 06:22am
Johnson & Johnson (NYSE:JNJ) reported quarterly earnings of $2.71 per share which beat the analyst consensus estimate of $2.64 by 2.65 percent. This is a 12.45 percent increase over earnings of $2.41 per share from the same period last year. The company reported quarterly sales of $21.383 billion which missed the analyst consensus estimate of $21.398 billion by 0.07 percent. This is a 2.34 percent increase over sales of $20.894 billion the same period last year.

Posted In: JNJ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist